查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1738371

細胞健康篩檢市場－全球產業規模、佔有率、趨勢、機會和預測（按測試類型、按樣本、按採集地點、按地區和競爭情況分類，2020 年至 2030 年預測）

Cellular Health Screening Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Test Type, By Sample, By Site of Collection, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球細胞健康篩檢市場規模為 33.2 億美元，預計到 2030 年將達到 56.7 億美元，複合年成長率為 9.33%。由於生活方式相關的健康風險、全球人口老化以及糖尿病、肥胖症和癌症等疾病的增多，該市場正在經歷顯著成長。旨在透過均衡飲食和規律體育鍛煉促進健康生活的端粒性能計劃的使用日益增多，進一步推動了市場需求。此外，直接面對消費者的檢測服務的日益普及以及人們對預期壽命和預防性醫療保健意識的提高也促進了市場擴張。隨著慢性病和與年齡相關的疾病變得越來越普遍，尤其是在老年人群中，對細胞健康篩檢的需求有望增加。不良飲食習慣導致癌症發生率上升，也刺激了市場發展，進一步強調了早期發現和個人化健康評估的需求。

市場概覽
預測期 2026-2030
2024年市場規模 33.2億美元
2030年市場規模 56.7億美元
2025-2030 年複合年成長率 9.33%
成長最快的領域 多測試面板
最大的市場 北美洲

關鍵市場促進因素

慢性病盛行率上升

主要市場挑戰

成本高且可近性有限

主要市場趨勢

篩選方法中先進技術的整合

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球細胞健康篩檢市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依測試類型（單測試板、多測試板）
    • 通過樣本（血液、唾液、尿液、其他）
    • 依收集地點（家庭、醫院和診所、診斷實驗室、其他）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖
    • 按測試類型
    • 按樣本
    • 按收集地點
    • 按地區

第6章：北美細胞健康篩檢市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲細胞健康篩檢市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太細胞健康篩檢市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美細胞健康篩檢市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東和非洲細胞健康篩檢市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 最新動態
  • 併購
  • 產品發布

第 13 章：全球細胞健康篩檢市場：SWOT 分析

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品/服務的威脅

第 15 章：競爭格局

  • Telomere Diagnostics, Inc.
  • Quest Diagnostics, Inc.
  • Laboratory Corporation of America Holdings
  • SpectraCell Laboratories, Inc.
  • Cell Science Systems Corporation
  • Immundiagnostik AG
  • Repeat Diagnostics, Inc.
  • OPKO Health, Inc.
  • Genova Diagnostics, Inc.
  • Titanovo, Inc.

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 14418

The Global Cellular Health Screening Market was valued at USD 3.32 billion in 2024 and is projected to reach USD 5.67 billion by 2030, expanding at a CAGR of 9.33%. The market is witnessing significant growth due to lifestyle-related health risks, an aging global population, and a rise in conditions such as diabetes, obesity, and cancer. The increasing use of telomere performance programs, aimed at promoting healthy living through balanced diets and regular physical activity, is further driving market demand. Additionally, the growing popularity of direct-to-consumer testing services and heightened awareness around life expectancy and preventive healthcare contribute to market expansion. As chronic diseases and age-related conditions become more prevalent, especially among the elderly, the demand for cellular health screening is poised to grow. The market is also being fueled by poor dietary habits leading to rising cancer incidence, further reinforcing the need for early detection and personalized health assessments.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 3.32 Billion
Market Size 2030USD 5.67 Billion
CAGR 2025-20309.33%
Fastest Growing SegmentMulti Test Panels
Largest MarketNorth America

Key Market Drivers

Rising Prevalence of Chronic Diseases

The global surge in chronic conditions-including diabetes, cancer, and cardiovascular diseases-is a major factor accelerating growth in the cellular health screening market. These diseases often develop without early symptoms, making timely detection essential. Cellular health screening helps identify changes at the cellular level before symptoms appear, enabling earlier interventions and more personalized treatment strategies. According to the WHO, chronic illnesses are responsible for 71% of all global deaths. In the U.S., CDC data shows that 6 in 10 adults suffer from at least one chronic disease, and 4 in 10 deal with two or more. This highlights the critical need for reliable and accessible early screening tools. In response, governments are investing in preventive healthcare innovations, such as the UK's funding of a £120 blood test for early cancer detection. As cellular health screening becomes more integrated into routine healthcare, it is expected to support better patient outcomes, reduce healthcare expenditures, and propel market growth.

Key Market Challenges

High Costs and Limited Accessibility

The high cost of cellular health screening technologies remains a major challenge to broader adoption. Procedures like telomere analysis and oxidative stress testing often require sophisticated laboratory infrastructure and trained personnel, increasing expenses for providers and patients alike. This cost burden is particularly significant in developing countries where access to healthcare services is already limited. WHO estimates indicate that over 1 billion people worldwide are unable to obtain basic health services due to financial constraints. Additionally, in many regions, these screening procedures are not covered by insurance, further limiting accessibility. The lack of affordable, scalable options and reimbursement frameworks makes it difficult for a broader population to benefit from early disease detection, underscoring the need for cost-effective innovations and inclusive health policies.

Key Market Trends

Integration of Advanced Technologies in Screening Methods

Technological advancements such as artificial intelligence (AI), machine learning, and high-throughput sequencing are playing a transformative role in cellular health screening. These innovations are improving the precision, speed, and efficiency of screening procedures, allowing for the detailed analysis of cellular and genetic data. AI-driven systems can identify early disease indicators by processing large volumes of data, while high-throughput sequencing offers deep insights into genomic profiles. Such technologies support personalized healthcare approaches, enabling treatments tailored to individual biological conditions. Government funding and industry partnerships are further supporting this technological shift. As these tools become more refined and widespread, they are expected to significantly enhance diagnostic capabilities and expand the market's reach, ultimately improving healthcare outcomes on a global scale.

Key Market Players

  • Telomere Diagnostics, Inc.
  • Quest Diagnostics, Inc.
  • Laboratory Corporation of America Holdings
  • SpectraCell Laboratories, Inc.
  • Cell Science Systems Corporation
  • Immundiagnostik AG
  • Repeat Diagnostics, Inc.
  • OPKO Health, Inc.
  • Genova Diagnostics, Inc.
  • Titanovo, Inc.

Report Scope:

In this report, the Global Cellular Health Screening Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cellular Health Screening Market, By Test Type:

  • Single Test Panels
  • Multi Test Panels

Cellular Health Screening Market, By Sample:

  • Blood
  • Saliva
  • Urine
  • Others

Cellular Health Screening Market, By Site of Collection:

  • Home
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Others

Cellular Health Screening Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Cellular Health Screening Market.

Available Customizations:

Global Cellular Health Screening Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cellular Health Screening Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Test Type (Single Test Panels, Multi Test Panels)
    • 5.2.2. By Sample (Blood, Saliva, Urine, Others)
    • 5.2.3. By Site of Collection (Home, Hospitals & Clinics, Diagnostic Laboratories, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map
    • 5.3.1. By Test Type
    • 5.3.2. By Sample
    • 5.3.3. By Site of Collection
    • 5.3.4. By Region

6. North America Cellular Health Screening Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Test Type
    • 6.2.2. By Sample
    • 6.2.3. By Site of Collection
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cellular Health Screening Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Test Type
        • 6.3.1.2.2. By Sample
        • 6.3.1.2.3. By Site of Collection
    • 6.3.2. Canada Cellular Health Screening Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Test Type
        • 6.3.2.2.2. By Sample
        • 6.3.2.2.3. By Site of Collection
    • 6.3.3. Mexico Cellular Health Screening Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Test Type
        • 6.3.3.2.2. By Sample
        • 6.3.3.2.3. By Site of Collection

7. Europe Cellular Health Screening Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Test Type
    • 7.2.2. By Sample
    • 7.2.3. By Site of Collection
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Cellular Health Screening Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Test Type
        • 7.3.1.2.2. By Sample
        • 7.3.1.2.3. By Site of Collection
    • 7.3.2. Germany Cellular Health Screening Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Test Type
        • 7.3.2.2.2. By Sample
        • 7.3.2.2.3. By Site of Collection
    • 7.3.3. United Kingdom Cellular Health Screening Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Test Type
        • 7.3.3.2.2. By Sample
        • 7.3.3.2.3. By Site of Collection
    • 7.3.4. Italy Cellular Health Screening Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Test Type
        • 7.3.4.2.2. By Sample
        • 7.3.4.2.3. By Site of Collection
    • 7.3.5. Spain Cellular Health Screening Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Test Type
        • 7.3.5.2.2. By Sample
        • 7.3.5.2.3. By Site of Collection

8. Asia-Pacific Cellular Health Screening Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Test Type
    • 8.2.2. By Sample
    • 8.2.3. By Site of Collection
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Cellular Health Screening Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Test Type
        • 8.3.1.2.2. By Sample
        • 8.3.1.2.3. By Site of Collection
    • 8.3.2. India Cellular Health Screening Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Test Type
        • 8.3.2.2.2. By Sample
        • 8.3.2.2.3. By Site of Collection
    • 8.3.3. Japan Cellular Health Screening Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Test Type
        • 8.3.3.2.2. By Sample
        • 8.3.3.2.3. By Site of Collection
    • 8.3.4. South Korea Cellular Health Screening Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Test Type
        • 8.3.4.2.2. By Sample
        • 8.3.4.2.3. By Site of Collection
    • 8.3.5. Australia Cellular Health Screening Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Test Type
        • 8.3.5.2.2. By Sample
        • 8.3.5.2.3. By Site of Collection

9. South America Cellular Health Screening Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Test Type
    • 9.2.2. By Sample
    • 9.2.3. By Site of Collection
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Cellular Health Screening Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Test Type
        • 9.3.1.2.2. By Sample
        • 9.3.1.2.3. By Site of Collection
    • 9.3.2. Argentina Cellular Health Screening Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Test Type
        • 9.3.2.2.2. By Sample
        • 9.3.2.2.3. By Site of Collection
    • 9.3.3. Colombia Cellular Health Screening Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Test Type
        • 9.3.3.2.2. By Sample
        • 9.3.3.2.3. By Site of Collection

10. Middle East and Africa Cellular Health Screening Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Test Type
    • 10.2.2. By Sample
    • 10.2.3. By Site of Collection
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Cellular Health Screening Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Test Type
        • 10.3.1.2.2. By Sample
        • 10.3.1.2.3. By Site of Collection
    • 10.3.2. Saudi Arabia Cellular Health Screening Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Test Type
        • 10.3.2.2.2. By Sample
        • 10.3.2.2.3. By Site of Collection
    • 10.3.3. UAE Cellular Health Screening Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Test Type
        • 10.3.3.2.2. By Sample
        • 10.3.3.2.3. By Site of Collection

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Cellular Health Screening Market: SWOT Analysis

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products/Services

15. Competitive Landscape

  • 15.1. Telomere Diagnostics, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Quest Diagnostics, Inc.
  • 15.3. Laboratory Corporation of America Holdings
  • 15.4. SpectraCell Laboratories, Inc.
  • 15.5. Cell Science Systems Corporation
  • 15.6. Immundiagnostik AG
  • 15.7. Repeat Diagnostics, Inc.
  • 15.8. OPKO Health, Inc.
  • 15.9. Genova Diagnostics, Inc.
  • 15.10. Titanovo, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer